All News

As we approach the end of the year, take the necessary time to review your financial planning strategies. A lot can happen in a year.

Long-term testosterone therapy in hypogonadal men improves urinary function and erectile function compared with untreated controls, according to registry data from a single practice.

“I think we’re seeing more younger men coming in with erectile dysfunction, because there’s just a lot more publicity about the issue," one urologist said.

"We strongly recommend that you obtain your practice QRUR regardless of your practice size and learn more about the report," write Ray Painter, MD, and Mark Painter.

Other pipeline developments discussed in this article include the initiation of an intravesical bladder cancer study, a gel treatment for ED that has met its primary endpoint, a patent awarded for the first rechargeable implantable SNM along with some other advancements.

The risk of prostate cancer relapse after radical prostatectomy increases with lengthening delay between diagnosis and surgery. The impact, however, is significant only in high-risk patients, and even in those men, there may be a window of up to 12 months during which it may be relatively safe to postpone surgery, reported researchers from Milan, Italy.

In this interview, Daniel Shoskes, MD, discusses his evaluation of patients with scrotal pain, outlines his use of conservative treatments, and explains surgical approaches and how he decides whether to use them.

As a practicing urologist, it is in your best interest to understand what a spoliation charge means in the state where you practice and the requirements of proof.

A new study revealing 91% of very low-risk and 74% of low-risk prostate cancer patients in Sweden choose active surveillance should be a benchmark for the use of the management strategy in the U.S. and elsewhere in the world, the study’s authors say.

Through UROPAC - Urology's Advocate on Capitol Hill, the AACU recently redoubled its commitment to connect urologists with their representatives and has found early success in doing so.

Bilateral replacement of the uterosacral ligaments with a polyvinylidene fluoride (PVDF) mesh (DynaMesh, FEG Textiltechnik mbH) is more effective than medical treatment with solifenacin (Vesicare) for achieving continence in women with urgency urinary incontinence (UUI) associated with only minor pelvic organ prolapse, according to the interim results of a prospective, randomized, crossover clinical trial.

Hypogonadism in men undergoing artificial urinary sphincter (AUS) implantation significantly increases the risk of cuff erosion, according to the results of a study presented by urologists from UT Southwestern Medical Center, Dallas.

Nearly 100% of patients with clinically localized prostate cancer, detected by PSA testing, survive at an average 10 years’ follow-up, regardless of whether they had active monitoring, radical prostatectomy, or radiotherapy, according to new study results.

A panel of experts, including several urologists, has approved nine resolutions on what they say is evidence-based clarity on male hypogonadism and how to manage it.

A new study finds that treatment with testosterone solution 2% can be effective for hypogonadism with no new safety concerns.

In his recent blog post “My $4.07 check: A sign of the times,” Henry Rosevear, MD, shared how, after managing a patient with an obstructing stone and billing $1,332.25 for his services, he received a check from the Colorado Indigent Care Program, the patient’s insurer, for $4.07. His blog post prompted a wave of comments, commiseration, and suggestions.

In this video, M. Chad Wallis, MD, demonstrates the Cohen cross-trigonal ureteral reimplant, considered the most commonly performed open reimplant procedure.

In this video, Chester J. Koh, MD, shows key steps in a top-down approach without the use of stents for robot-assisted extravesical ureteral reimplantation.

Responding to physicians’ data-driven arguments, including a December 2014 JAMA study showing maintenance of certification (MOC) programs do not improve patient outcomes (JAMA 2014; 312:2348-57), state legislators proposed several new laws in 2016.

Results from a multicenter study show progression-free survival in 97% of low- and intermediate-risk prostate cancer patients.

"This is the step whereby practices can apply good, evidence-based, pathway-driven medicine to not only provide excellent outcomes for patients, but also be financially successful in the process," writes Henry Rosevear, MD.

Findings from a recent study indicate that CTCs detected in blood have the potential to reveal important genetic information that could guide treatment selection.

Another study suggests that hemiablation with high-intensity focused ultrasound is a promising treatment for unilateral localized prostate cancer.

New research suggests that urologists can use the Decipher genetic test (GenomeDx Biosciences) to improve predictions of death risk from prostate cancer at10 years after prostatectomy.

A recently approved treatment for urothelial carcinoma provides durable responses when used as first-line treatment in patients who are ineligible for cisplatin-based therapy, according to a recent study.

In this article, we will provide an overview of the urologist’s role in caring for patients undergoing gender transition as well as urologic concerns of transgender men and women.

Recent data show that a low-carbohydrate diet may have significant positive effects in men on hormonal therapy for prostate cancer, including metabolic effects. In this interview, study author Stephen J. Freedland, MD, discusses his group’s findings, ongoing research on diet and lifestyle changes in men with prostate cancer, and how he counsels patients.